In the current study, the somatic mutations, including missense and truncation, in the EPHA5 gene in the NSCLC patients were found in 7.6% (65/853) NSCLC patients in the OAK and POPLAR cohorts. Here, EPHA5 is linked to non-small cell lung carcinoma.